ELHT Vitamin D Guidelines – Children - approved for use.
Rifaximin added to formulary for hepatic encephalopathy, for consultant gastroenterologist use only and a protocol. Traffic light: RED
Simeprevir to be included in formulary if NICE approve in January.
Pentoxifylline & Vitamin E for osteonecrosis of the jaw approved subject to satisfactory supply arrangements.
Osvaren included in formulary for renal use. Traffic Light: AMBER
Certolizumab - of adults with ankylosing spondylitis in line

NOAC's position Statement - The position statement with a preferred option NOAC will not be pursued and all three will be available for prescribing, with traffic light remaining Amber.
NEW PRODUCT REQUESTS – CARBETOCIN and AZARGA EYE DROPS- deferred

All material in this section is aimed at health professionals, but is information currently held within the public domain. Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.